Growth Hormone
Ipamorelin
Selective growth hormone secretagogue with minimal side effects
Popular
Reference summary
- Category
- Growth Hormone
- Typical reference dosing
- 200-300mcg 2-3x/day SC
Dosing shown is a published educational reference range only. It is not a prescription, not a protocol, and not a recommendation for any individual. Any use of peptide therapy requires evaluation and supervision by a licensed clinician.
How this fits a care plan
At the DRC, compounds like Ipamorelin are only ever discussed after history, examination, and appropriate lab work. We review candidacy, alternatives, expected timelines, monitoring, and when a compound is not appropriate. If a request for Ipamorelin is submitted through our protocol request form, it is reviewed by a clinician before any response.
Related in Growth Hormone
CJC-1295
Growth hormone releasing hormone analog for anti-aging
GHRP-2
Growth hormone releasing peptide for GH stimulation
GHRP-6
Growth hormone releasing peptide with appetite stimulation
Hexarelin
Growth hormone secretagogue with cardiac benefits
Ibutamoren (MK-677)
Oral growth hormone secretagogue for GH optimization
IGF-1 LR3
Long-acting insulin-like growth factor for muscle growth
Next step
Begin with a conversation, not a procedure.
Every plan at the DRC starts with testing, options, and written pricing. Consultations carry no obligation to treat.
Request a consultation86 compounds indexed. Back to the full A–Z library.